AI Insight
This cross-sectional study of 102 adult asthma patients found that 51% showed signs of depression, with poor asthma control and low medication adherence strongly associated with increased depressive symptoms and reduced quality of life. Objective measures like lung function tests and allergy markers showed weak or no association with emotional outcomes, suggesting that patients' subjective experience of disease control matters more than physiological measurements for mental health.
Why it matters
The findings indicate that asthma care should incorporate psychological support and self-management training rather than focusing solely on biological markers. This could lead to more effective treatment strategies that address both the physical and emotional dimensions of living with chronic asthma.
Understand the Science
IntroductionAsthma is a chronic inflammatory respiratory disease that is frequently associated with emotional distress and impaired quality of life. However, how clinical factors, such as treatment, adherence, lung function, and allergy sensitization, relate to depressive symptoms remains unclear. In this study, we examined the associations among asthma control, treatment, adherence, lung function, allergy sensitization, somatic and cognitive-affective depressive symptoms, and quality of life in a real-life clinical setting.MethodsThis cross-sectional study included adults with asthma attending tertiary pneumology and allergy services, and their asthma symptoms were evaluated using the standardized measures of the Asthma Control Test, GINA 2022 (treatment), Test of Adherence to Inhalers, lung function, skin prick test for allergy sensitization, PHQ-9 (depressive symptoms), Asthma Quality of Life Questionnaire, serum eosinophils and IgE levels.ResultsOf 102 asthma patients, 51% of participants scored more than 5 points on the PHQ-9, indicating the presence of depression. Poor asthma control and lower adherence scores were significantly associated with higher depressive symptoms (rs = −0.36, p< 0.001; rs = 0.41, p< 0.001) and poorer quality of life (rs = 0.50, p< 0.001), whereas objective lung function like reduced forced vital capacity (rs = 27, p = 0.05) was weakly associated with depressive symptoms. Eosinophils count (rs = 0.02), IgE (rs = 0.06) or allergy sensitization (rs = 0.08) markers showed nonsignificant associations with emotional outcomes.ConclusionEmotional distress and quality of life are more strongly related to patients’ perceived control of their disease and adherence behaviors than to objective physiological markers. Thus, psychological and self-management strategies should be integrated into routine asthma care.